# China NMPA Inspection - Qinghai Baichen Pharmaceutical Co., Ltd. - August 24, 2018

Source: https://www.globalkeysolutions.net/records/china_inspection/qinghai-baichen-pharmaceutical-co-ltd/ea7afc8a-46dc-4db3-af04-7f4edcb728f5/
Source feed: China

> China NMPA unannounced inspection for Qinghai Baichen Pharmaceutical Co., Ltd. published August 24, 2018. The National Medical Products Administration (NMPA) of China issued a notification on August 24, 2018, regarding an unannounced inspection of Qinghai 

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Qinghai Baichen Pharmaceutical Co., Ltd.
- Company Name: Qinghai Baichen Pharmaceutical Co., Ltd.
- Publication Date: 2018-08-24
- Product Type: drugs
- Summary: The National Medical Products Administration (NMPA) of China issued a notification on August 24, 2018, regarding an unannounced inspection of Qinghai Baichen Pharmaceutical Co., Ltd. The document, titled "Notification of Unannounced Inspection of Qinghai Baichen Pharmaceutical Co., Ltd.", indicates that the regulatory body conducted an unscheduled review of the pharmaceutical company. While the notification confirms the event's occurrence and its publication date, the provided content is limited to administrative details such as the publishing authority and website information. Critical details typically found in an inspection summary are absent from this text. Specifically, the document does not disclose the actual inspection dates, any specific violations or issues identified during the inspection, the particular regulatory framework under which findings were made, or any required actions that Qinghai Baichen Pharmaceutical Co., Ltd. must undertake to address deficiencies. Therefore, a comprehensive summary including these crucial aspects cannot be generated based solely on the provided notification text.

Company: https://www.globalkeysolutions.net/companies/qinghai-baichen-pharmaceutical-co-ltd/56c6f371-ae5b-400f-a0f7-f9d9a5cf04b0/